Cargando…
New Directions in the Study and Treatment of Metastatic Cancer
Traditional cancer therapy has relied on a strictly cytotoxic approach that views non-metastatic and metastatic tumor cells as identical in terms of molecular biology and sensitivity to therapeutic intervention. Mounting evidence suggests that, in fact, non-metastatic and metastatic tumor cells diff...
Autores principales: | Yoo, Byunghee, Fuchs, Bryan C., Medarova, Zdravka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048200/ https://www.ncbi.nlm.nih.gov/pubmed/30042926 http://dx.doi.org/10.3389/fonc.2018.00258 |
Ejemplares similares
-
Guidelines for Rational Cancer Therapeutics
por: Yoo, Byunghee, et al.
Publicado: (2017) -
MiRNA10b-directed nanotherapy effectively targets brain metastases from breast cancer
por: Yoo, Byunghee, et al.
Publicado: (2021) -
Screening of potential miRNA therapeutics for the prevention of multi-drug resistance in cancer cells
por: Medarova, Zdravka, et al.
Publicado: (2020) -
MicroRNA-710 regulates multiple pathways of carcinogenesis in murine metastatic breast cancer
por: Yoo, Byunghee, et al.
Publicado: (2019) -
Case report: MicroRNA-10b as a therapeutic target in feline metastatic mammary carcinoma and its implications for human clinical trials
por: Savan, N. Anna, et al.
Publicado: (2022)